Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China

Background and aims: Clinical data regarding patients with chronic hepatitis B (CHB) after Omicron BA.5 infection are currently limited. This study aimed to assess the clinical characteristics of patients with CHB and Omicron BA.5 infection in South China. Methods: This retrospective study was condu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peipei Wang, Junjian Chen, Dabiao Chen, Ziying Lei, Zhishuo Mo, Ying Zhang
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-03-01
Series:	Liver Research
Subjects:	Hepatitis B virus (HBV) Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.5 Entecavir (ETV)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2542568424000643
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
by: Qianhui Wu, et al.
Published: (2023-12-01)

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States
by: Kien Pham, et al.
Published: (2025-05-01)

Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections
by: Noah Brazer, et al.
Published: (2025-07-01)

Differences in chest imaging between Omicron and non–Omicron coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
by: Yingying Han, et al.
Published: (2025-04-01)

Risk Predictors for Mortality in Inpatients with Cancer and Coronavirus Disease 2019 during the Omicron Wave
by: Kuan-Yu Chen, et al.
Published: (2023-10-01)

Impact of Omicron BA.5 infection on maternal and neonatal outcomes
by: Lu Li, et al.
Published: (2025-05-01)

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia
by: Eida Nurhadzira Muhammad, et al.
Published: (2025-06-01)

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
by: Bradley K. Ackerson, et al.
Published: (2024-12-01)

Molecular Determinants for the Binding of the Highly Infectious SARS-CoV-2 Omicron (BA.1) Variant to the Human ACE2 Receptor
by: Majed S. Aljohani, et al.
Published: (2025-02-01)

The Outcome of BA.5 Omicron in Transplant Cases: A Retrospective Single-center Study in Jeddah Saudi Arabia
by: Mona A. Bahasan, et al.
Published: (2025-01-01)

Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study
by: Shihan Zhang, et al.
Published: (2024-10-01)

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

The association between chronic underlying diseases and the clinical characteristics in adult patients infected with Omicron BA.1
by: Jingyu Wang, et al.
Published: (2025-06-01)

Epidemiology and Clinical Characteristics of Laboratory-Confirmed COVID-19 and Influenza Infections in Children: A 2015–2024 Study in Taiwan
by: Hao-Yuan Lee, et al.
Published: (2025-02-01)

Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China
by: Wenfang Yuan, et al.
Published: (2024-12-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Primary partial response with tenofovir monotherapy: two adults and one child
by: Habip Gedik
Published: (2022-05-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Electronic Interactions Between the Receptor-Binding Domain of Omicron Variants and Angiotensin-Converting Enzyme 2: A Novel Amino Acid–Amino Acid Bond Pair Concept
by: Puja Adhikari, et al.
Published: (2025-05-01)

The Race to Find COVID-19 Vaccine: So Near, Yet so Far!
by: Sonali Sachdeva, et al.
Published: (2020-10-01)

Coronavirus disease COVID-2019
by: B. K. Romanov
Published: (2020-03-01)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis
by: Nowicka AA, et al.
Published: (2024-12-01)

Evaluation of broad-spectrum protection by novel mRNA vaccines against SARS-CoV-2 variants (Delta, Omicron-BA.5, XBB-EG.5) in the golden hamster model
by: Tong Yu, et al.
Published: (2025-05-01)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01)

Co-Infection with COVID-19 and Malaria in a Young Man
by: Mustafa Mahmood Eid
Published: (2021-03-01)

Severe Acute Respiratory Syndrome Coronavirus-2 and Tuberculosis Coinfection: Double Trouble
by: Abhijeet Singh, et al.
Published: (2020-07-01)

Association of Clinicodemographic Factors and Vaccination Status with COVID-19 Positivity in a Tertiary Care Hospital in Southern India: A Cross-sectional Study
by: Soumya Kaup, et al.
Published: (2025-03-01)

Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance
by: Rauschning, Dominic, et al.
Published: (2025-02-01)

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
by: Behnam Amani, et al.
Published: (2021-12-01)

Perceptions and Beliefs on Vaccination for COVID-19 in Delhi: A Cross-Sectional Study
by: Abha Sharma, et al.
Published: (2021-07-01)

The COVID-19 vaccine: A race nearing the finish line
by: Tarun Kumar Suvvari, et al.
Published: (2021-01-01)

Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
by: Vaidyanathan Gowri, et al.
Published: (2024-01-01)

Biodiversity and epidemic potential of Chiropteran coronaviruses (<i>Nidovirales: Coronaviridae</i>)
by: A. M. Shestopalov, et al.
Published: (2020-08-01)

First-principles calculations to investigate the bulk, electronic, optical and thermoelectric properties of BaGe2As2 and BaGe2P2 alloys
by: Debora Nameme, et al.
Published: (2024-12-01)

Predictors of atrial fibrillation in patients with COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01)

Do we need coronavirus vaccination today?
by: K. K. Tikhomirova, et al.
Published: (2023-10-01)

Sudden onset of olfactory and gustatory dysfunctions in coronavirus disease 2019 (COVID-19) is momentous marker
by: Himani Tiwari Chaturvedi, et al.
Published: (2021-01-01)